MINERVA NEUROSCIENCES INC has a total of 67 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are WUHAN UNITED PHARMACEUTICAL CO LTD, VIRONOVA HERPES AB and PFLEGER R CHEM FAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Australia | 8 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Canada | 5 | |
#6 | Israel | 5 | |
#7 | Brazil | 3 | |
#8 | Chile | 2 | |
#9 | China | 2 | |
#10 | Mexico | 2 | |
#11 | New Zealand | 2 | |
#12 | Peru | 2 | |
#13 | Philippines | 2 | |
#14 | Singapore | 2 | |
#15 | Colombia | 1 | |
#16 | Republic of Korea | 1 | |
#17 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Telecommunications | |
#5 | Digital networks |
# | Name | Total Patents |
---|---|---|
#1 | Luthringer Remy | 47 |
#2 | Noel Nadine | 22 |
#3 | Pellegrini Lorenzo | 22 |
#4 | Werner Sandra | 18 |
#5 | Karabelas Argeris | 17 |
#6 | Luthringer Remy Henri | 10 |
#7 | Saoud Jay | 10 |
#8 | Okuyama Masahiro | 10 |
#9 | Georgi Emmanuelle | 6 |
#10 | Karabelas Argeris N | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020101790A2 | Methods of using a phenoxypropylamine compound to treat pain | |
US2020061046A1 | Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection | |
EP3641732A1 | Gastro-resistant controlled release oral dosage forms | |
US2019183874A1 | (2s)-1-[4-(3,4-dichlorophenyl)piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl)benzo[b]furan-4-yloxy] propan-2-ol or its metabolite for treating anxiety disorders | |
WO2016089766A1 | Compositions comprising 2-((1-(2(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one for treating schizophrenia |